The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates.
Analysts expect Salesforce to report first-quarter earnings of $2.38 per share and quarterly revenue of $9.147 billion, according to estimates from Benzinga Pro. Salesforce has a strong track record of beating analyst estimates on the top and bottom lines.